跳到正文 / Skip to main content
LAWMAY路迈

Insights

From Record Lows to Targeted Enforcement: Reading the 2025 U.S. Youth Tobacco Survey Data

Author

Hongchang Deng · 邓宏昌

美国(加州)执业律师(Bar #354529)· USPTO · 中国专利代理师

 

Yi Yi · 易伊

美国(加州)执业律师

Published

2026-08-07 · 23 min read

TL;DR

Youth tobacco use hit a record low — but Chinese-manufactured brands took the top four places among youth e-cigarette users, with one holding more than 60%. That official data now gives the FDA a targeting basis.

On June 23 and 24, 2026, the FDA released two sets of data in succession: the results of the 2025 National Youth Tobacco Survey (NYTS) with an accompanying peer-reviewed paper, and a significant study demonstrating the effectiveness of its public health advertising. The timing was deliberate. Just as the FDA's capacity to authorize flavored e-cigarettes and to act against illegal products was being repeatedly questioned, the data supplied regulators with a self-consistent rationale: youth tobacco use continues to decline and the advertising interventions are demonstrably effective, so newly authorized flavored products rest on a reasonable basis.

Within the same data, however, lies a warning of real importance to Chinese vape exporters: in the 2025 NYTS ranking of brands most commonly used by youth e-cigarette users, Chinese-manufactured brands took the top four places, with one brand alone accounting for more than 60% of youth users. That official survey data is now providing the targeting basis for the FDA's current and future enforcement. This note reviews the substance of the releases and reads the legal signals of practical significance to exporters. It is a general overview and does not constitute legal advice on any particular matter.

I. What Was Released

1. NYTS 2025: Record-Low Youth Tobacco Use, but Flavor and Brand Composition Remain Serious

On June 23, 2026, the FDA published the 2025 NYTS data and announced a peer-reviewed paper in Nicotine & Tobacco Research. The survey covers U.S. middle and high school students. Principal findings:

  • In 2025, 7.2% of U.S. middle and high school students — about 2 million — reported current use (any use in the past 30 days) of any tobacco product, a record low.
  • From 2022 to 2025, overall youth tobacco use, e-cigarette use, and cigarette use all declined steadily.
  • E-cigarettes remain the most used category, with 5.2% of students (about 1.44 million) reporting current use — down from 5.9% in 2024, though the two-year change was not statistically significant.
  • About 90% of current e-cigarette users used flavored products, with fruit flavors the most popular.
  • The brands most commonly used by youth e-cigarette users in 2025: Geek Bar (64.1%), Elf Bar (21.5%), Lost Mary (19.8%), Raz (19.5%), Vuse (15.9%) — the top four all Chinese-manufactured.
  • Nicotine pouch use was 1.7%, essentially flat against 2024 and low overall.
  • Among nicotine pouch users, ZYN led at 69.2% and on! was second at 14.6%; more than 90% used flavored products, with menthol the most popular.

2. "The Real Cost" Prevention Campaign: 444,000 Youth Prevented From Starting; $42 Million in Illegal Sales Averted

On June 24, 2026, the FDA announced a special issue of the American Journal of Preventive Medicine presenting ten years of results from "The Real Cost" youth e-cigarette prevention campaign. The issue contains twelve peer-reviewed papers and a commentary from Bret Koplow, Acting Director of the FDA's Center for Tobacco Products. Principal findings:

  • Headline result: one study found the campaign prevented approximately 444,000 U.S. youth from beginning e-cigarette use between 2023 and 2024.
  • Economic quantification: the FDA estimates that prevention also averted more than $42 million in illegal e-cigarette purchases over the same period.
  • Reach: 75% of youth surveyed saw at least one e-cigarette prevention advertisement during the study period; the campaign also drove more than 253,000 visits to the National Cancer Institute's youth smoking cessation site in 2021–2022.
  • Ten-year analysis: a decade of advertising testing data shows the FDA's tobacco prevention advertising has been consistently effective in changing youth attitudes and perceptions, with e-cigarette prevention advertising particularly so.

The FDA is exploring extending this advertising strategy to adult smokers — preventing youth access while helping adult smokers understand how to reduce tobacco harm.

II. Reading the Signals: Three Practical Trends

1. NYTS Data Now Serves Both Enforcement and Authorization Decisions

The timing of the release repays attention. On one hand, continued declines in youth e-cigarette use directly support the FDA's earlier authorization of Glas flavored products: use is at a manageable level, and introducing flavored products with device access restriction (DAR) technology does not harm public health but rather provides an alternative for adults seeking to quit.

In the nicotine pouch category, ZYN — with years of market leadership and the first-mover advantage of PMTA authorization — has built a substantial compliance barrier. Brands entering later must show through data that their user base is predominantly adult with low youth penetration; that is among the baseline thresholds for PMTA review.

2. Youth Use Is at a Record Low — but Their Leading Brand Is Unauthorized

Following the release, the major U.S. public health organizations — the American Heart Association, the Campaign for Tobacco-Free Kids, Truth Initiative, and others — responded consistently: the decline in youth tobacco use is genuine progress and should be acknowledged, but it cannot obscure a troubling fact — most of what youth users hold remains product the FDA has never authorized.

Put differently, the decline in overall youth use comes principally from the combined effect of public education and enforcement; the share of illegal product in youth channels has not contracted correspondingly. Geek Bar leads at 64.1% of youth users and remains without PMTA authorization — a paradigm illegal product on sale. That indicates enforcement remains limited in effect: large volumes of unauthorized product continue to circulate normally, and it is precisely that product youth encounter most.

The American Heart Association also observed that the data was released immediately after the FDA authorized mango and blueberry flavored e-cigarettes — timing that is itself a concern, given that nearly 90% of youth e-cigarette users use flavored products and fruit flavors are the most popular.

Against that background, the FDA's decision to expand flavor authorizations will inevitably invite questions about whether it will increase youth exposure to flavored products.

For Chinese exporters the message is clear: the room to maintain a market presence on the assumption that illegal products are too numerous, regulatory resources too limited, and enforcement too slow to reach you is being systematically compressed. Multi-agency enforcement will only intensify.

3. Build Adult-Use Evidence Now, Against the Youth Appeal Criteria in PMTA Review

NYTS has now told the public and PMTA reviewers plainly that fruit and candy/dessert flavors are the most popular among youth. For companies whose business rests on those flavors, a PMTA must contain adequate data establishing that the real target users are adult smokers rather than youth. Concretely: design and accumulate usage data across age groups in advance — user profiles, purchase channels, reasons for use, and cessation outcomes — and proactively avoid any visual or flavor element in product design and marketing materials that could be found appealing to youth. The earlier and more solidly that work is done, the lower the risk of deficiency letters or denial in PMTA review.

Closing

The two data releases of June 23–24, 2026 present, on their face, the interim results of U.S. youth tobacco control. In substance they may have clarified the direction of the next stage of enforcement: the fact that Chinese-manufactured brands dominate youth e-cigarette consumption has now formally entered the FDA's enforcement field of view in the form of official survey data. For the companies concerned, that is not a badge of market influence but a reference coordinate for targeted regulatory pressure. Undertaking a compliance assessment and planning strategically in advance is the response of greatest value now.

References

  1. American Heart Association, "As youth tobacco use declines, flavored e-cigarettes and nicotine pouches are a continued concern" (June 24, 2026)
  2. Campaign for Tobacco-Free Kids, "National Survey Shows Long-Term Drop in Youth Tobacco Use" (June 23, 2026)
  3. Eunice Park-Lee et al., "Tobacco product use among middle and high school students in the United States: NYTS 2025," Nicotine & Tobacco Research, ntag116 (June 23, 2026)
  4. Truth Initiative, "New Federal Study Highlights Progress on Youth E-Cigarette Use, but Nicotine Addiction Risks for Young People Remain" (June 24, 2026)
  5. U.S. FDA, "National Youth Tobacco Survey: FDA Publishes Peer-Reviewed Journal Article, Releases 2025 Findings" (June 23, 2026)
  6. U.S. FDA, "Results from the Annual National Youth Tobacco Survey (NYTS)" (updated June 23, 2026)
  7. U.S. FDA, "Studies Show FDA Educational Efforts Help Prevent Youth From Starting E-Cigarette Use, Illegal E-Cigarette Sales" (June 24, 2026)

This article addresses general legal questions only and does not constitute legal advice on any specific matter.

关于作者 / About the Authors

Richard Deng

Partner · LawMay P.C.

邓律师主要从事中国及美国商品及服务争议解决,以及专利、商标、版权、商业秘密等涉外知识产权诉讼与无效确权业务,并办理中美商标申请及中国专利申请。常年服务跨境工贸企业、跨境电商、电子烟行业、科技制造业等领域,为财富 500 强、国际连锁品牌、出海科技品牌等多家中外知名企业提供常年及专项法律服务。

在跨境电商争议领域,邓律师专注 Schedule A 批量诉讼的被告应对,包括临时限制令(TRO)项下的店铺账户与资金解冻、通过确认不侵权之诉(Declaratory Judgment,DJ)与「反向 TRO」动议争取恢复被下架的商品链接与店铺经营,以及亚马逊账户冻结申诉、品牌备案(Brand Registry)争议等平台纠纷的代理。在华盛顿州西区联邦法院,邓律师代理多起确认不侵权之诉(DJ),取得了恢复商品上架、并禁止对方继续投诉的「反向 TRO」与「反向初步禁令(反向 PI)」。他熟悉 Schedule A 案件高发的伊利诺伊州北区、佛州南区等联邦法院的程序节奏,能在中美时差下迅速响应、把握应诉与和解的时间窗口。

在涉外电子烟与 FDA 监管领域,邓律师为电子烟及新型烟草企业提供覆盖确权、合规到维权的全流程代理,涵盖行业知识产权维权与 337 调查、PMTA 上市前申请与 STN 状态争议、FDA 执法防御(警告信、营销拒绝令 MDO、进口扣留 Import Alert),以及美国海关(CBP)清关合规与扣押货物申诉。

他代理的知识产权相关案件多次荣获「广东省知识产权行政保护典型案例」「广东省商业秘密保护大事件」、「深圳律师承办知识产权十大典型案例」、「深圳市侵害商业秘密典型案例」、「深圳律师国际贸易、投资领域典型案例」、「广东知识产权保护协会年度知识产权推荐学习案例」等专业荣誉。

他代理的商品及服务贸易纠纷、知识产权等争议解决案件涉案标的额总计达数十亿元人民币。

美国联邦知识产权诉讼 · 跨境工贸与电商争议 · 电子烟与 FDA 监管 · 商业秘密与不正当竞争

Rdeng@lawmayus.com

+1 (213) 682-7241 · 美国 / US

+86 186 8156 7690 · 中国 / China,微信同号

Yi Yi

Non-Equity Partner · LawMay P.C.

易伊是美国加利福尼亚州执业律师,执业领域主要包括美国联邦法院知识产权诉讼、跨境电商争议、产品责任纠纷及联邦上诉案件。易伊代理中国及其他国际客户处理专利侵权、商标及著作权争议、产品责任纠纷、临时限制令与初步禁令、网络平台知识产权执法及其他跨境商事纠纷。

易伊经常协助客户应对临时限制令及初步禁令申请,挑战不当的管辖权主张,制定专利不侵权及无效抗辩,并协调中美两地的诉讼策略。易伊亦为跨境电商企业就知识产权执法、平台账户及商品链接争议、产品责任索赔及相关诉讼风险提供法律服务。

易伊具备在美国联邦巡回上诉法院、美国第十一巡回上诉法院、加州中区、北区联邦地区法院及德克萨斯东区、南区、伊利诺伊州北区联邦地区法院的出庭经验(涵盖正式执业资格与临时出庭许可 Pro Hac Vice / PHV 两种形式)。易伊亦办理美国专利商标局商标申请事务,并为美国知识产权法律协会会员。

美国联邦知识产权诉讼 · 跨境电商争议解决 · 联邦巡回上诉法院实务

Yiyi@lawmayus.com

+1 (747) 241-3130 · 美国 / US

+86 152 2005 1240 · 中国 / China,微信同号

About LawMay P.C.

美国路迈律师事务所(LawMay P.C.)

深耕中美跨境争议解决的美国精品律所。专注于美国联邦知识产权诉讼、337 调查、产品责任纠纷及重大商事争议。

Law May, We May.